Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0096 USD | +11.63% |
|
-.--% | -94.88% |
Jun. 25 | Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
May. 28 | Peak Bio, Inc. announced that it has received $1.3245 million in funding | CI |
Business Summary
Number of employees: 21
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Innovative Therapies
100.0
%
| - | - | 1 | 100.0 % | - |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen LaMond
CEO | Chief Executive Officer | - | 22-10-31 |
Director of Finance/CFO | 62 | 22-10-31 | |
Satyajit Mitra
BRD | Director/Board Member | 50 | 22-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Neal
BRD | Director/Board Member | 68 | 22-10-31 |
Ho Young Huh
CHM | Chairman | 54 | 22-10-31 |
Michael Friedman
BRD | Director/Board Member | - | 23-08-24 |
Stephen LaMond
CEO | Chief Executive Officer | - | 22-10-31 |
David Rosenberg
BRD | Director/Board Member | 50 | 22-10-31 |
Satyajit Mitra
BRD | Director/Board Member | 50 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,124,888 | 13,841,034 ( 59.85 %) | 0 | 59.85 % |
Company contact information
Peak Bio, Inc.
4900 Hopyard Road Suite 100
94588, Pleasanton
+
![address Peak Bio, Inc.(PKBO)](https://cdn.zonebourse.com/static/address/146232523.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-94.88% | 222K | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- PKBO Stock
- Company Peak Bio, Inc.